Work

A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human αv integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer

Year: 2010

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-010-9388-4

Authors: Franklin M. Chu, Joel Picus, Paula M. Fracasso, Robert Dreicer, Zhihui Lang, Brenda Foster

Institutions: Washington University in St. Louis, Alvin J. Siteman Cancer Center, Cleveland Clinic

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2015069347

FWCI: 3.469

Cites: 21

Cited by: 30

Related to: 10